257 reports of this reaction
3.0% of all DEXTROAMPHETAMINE SULFATE reports
#4 most reported adverse reaction
ANXIETY is the #4 most commonly reported adverse reaction for DEXTROAMPHETAMINE SULFATE, manufactured by Amneal Pharmaceuticals LLC. There are 257 FDA adverse event reports linking DEXTROAMPHETAMINE SULFATE to ANXIETY. This represents approximately 3.0% of all 8,480 adverse event reports for this drug.
Patients taking DEXTROAMPHETAMINE SULFATE who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANXIETY is a less commonly reported adverse event for DEXTROAMPHETAMINE SULFATE, but still significant enough to appear in the safety profile.
In addition to anxiety, the following adverse reactions have been reported for DEXTROAMPHETAMINE SULFATE:
The following drugs have also been linked to anxiety in FDA adverse event reports:
ANXIETY has been reported as an adverse event in 257 FDA reports for DEXTROAMPHETAMINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANXIETY accounts for approximately 3.0% of all adverse event reports for DEXTROAMPHETAMINE SULFATE, making it a notable side effect.
If you experience anxiety while taking DEXTROAMPHETAMINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.